Work

A phase I study of ruxolitinib in children with relapsed/refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group Phase I Consortium study (ADVL1011).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.10019

Authors: Sarah K. Tasian, Mignon L. Loh, Karen R. Rabin, Patrick Andrew Brown, Charlotte H. Ahern, Brenda Weigel, Susan Blaney

Institutions: Children's Hospital of Philadelphia, University of California, San Francisco, Texas Children's Hospital, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baylor College of Medicine, University of Minnesota

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600822259

Cites:

Cited by: 1

Related to: 10